Diagnostics
News and analysis on diagnostic technologies and applications.
Kura Oncology Advances Phase I/II Trial for Menin Inhibitor in Advanced AML
The company is currently enrolling around a dozen AML patients with NPM1 mutations or KMT2A rearrangements into two Phase Ib cohorts.
Liquid Biopsy Startup Adela Launches With $60M Series A Financing Round
The Toronto-based company will use the funding to commercialize its cell-free DNA methylation sequencing technology as an early cancer detection test.
Pfizer Studying Talzenna in Advanced Prostate Cancer Patients With DNA Damage Response Gene Defects
The Phase III trial will randomize metastatic castration-sensitive prostate cancer patients to Talzenna plus Xtandi or just Xtandi.
Clovis Oncology Begins Study of FAP-2286 Targeted Imaging Agent, Radionuclide Therapy
The Phase I/II LuMIERE study is enrolling patients with different types of tumors at the O'Neal Comprehensive Cancer Center in Alabama.
Genomic Testing Cooperative's Hematologic Neoplasms, Solid Tumor Tests Receive NY State Approval, Medicare Coverage
The next-generation sequencing-based tests can be performed on small samples, including needle aspiration samples, and use artificial intelligence software.